Get started
Author

Timo Piironen

Free, Complexed and Total Serum Prostate Specific Antigen: The Establishment of Appropriate Reference Ranges for their Concentrations and Ratios
1995 · Joseph E. Oesterling, Steven J. Jacobsen, et al. · The Journal of Urology · 317
Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex
1995 · K Pettersson, T Piironen, et al. · Clinical Chemistry · 190
Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum
1995 · K Mitrunen, K Pettersson, et al. · Clinical Chemistry · 173
In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to α1-antichymotrypsin in blood samples
1996 · Timo Piironen, Kim Pettersson, et al. · Urology · 128
In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic “gray zone” of total PSA 4 to 10 ng/mL
1998 · Maciej K Kwiatkowski, Franz Recker, et al. · Urology · 126
Prognostic significance of soluble urokinase plasminogen activator receptor in serum and cytosol of tumor tissue from patients with primary breast cancer.
2002 · Rikke Riisbro, Ib J Christensen, et al. · PubMed · 116
Discrimination of Prostate Cancer from Benign Disease by Plasma Measurement of Intact, Free Prostate-specific Antigen Lacking an Internal Cleavage Site at Lys145-Lys146
2001 · Pauliina Nurmikko, Kim Pettersson, et al. · Clinical Chemistry · 101
Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum
1996 · T Piironen, J Lövgren, et al. · Clinical Chemistry · 99
Summary Report of the TD-3 Workshop: Characterization of 83 Antibodies against Prostate-Specific Antigen
1999 · U.-H. Stenman, E. Paus, et al. · Tumor Biology · 95
Discrimination of Men With Prostate Cancer From Those With Benign Disease by Measurements of Human Glandular Kallikrein 2 (hk2) in Serum
2000 · CHARLOTTE BECKER, TIMO PIIRONEN, et al. · The Journal of Urology · 92
Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen
2000 · Franz Recker, Maciej K Kwiatkowski, et al. · Urology · 91
Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ‐confined from locally‐advanced prostate cancer in total PSA‐levels below 10 ng/ml
2001 · Alexander Haese, Markus Graefen, et al. · The Prostate · 88
Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater
2000 · Charlotte Becker, Timo Piironen, et al. · Urology · 85
Production of Recombinant PSA and HK2 and Analysis of Their Immunological Cross-Reactivity
1995 · J. Lovgren, T. Piironen, et al. · Biochemical and Biophysical Research Communications · 82
Rapid Exponential Elimination of Free Prostate-Specific Antigen Contrasts the Slow, Capacity-Limited Elimination of PSA Complexed to Alpha1-Antichymotrypsin From Serum
1998 · Thomas Björk, Bengt Ljungberg, et al. · Urology · 81
Production and Characterization of Novel Anti-Prostate-specific Antigen (PSA) Monoclonal Antibodies That Do Not Detect Internally Cleaved Lys145-Lys146 Inactive PSA
2000 · Pauliina Nurmikko, Ville Väisänen, et al. · Clinical Chemistry · 72
Sensitive and Specific Immunodetection of Human Glandular Kallikrein 2 in Serum
2000 · Charlotte Becker, Timo Piironen, et al. · Clinical Chemistry · 69
Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer
1996 · Thomas BjÖrk, Timo Piironen, et al. · Urology · 68
Reproducibility and Accuracy of Measurements of Free and Total Prostate-Specific Antigen in Serum vs Plasma after Long-Term Storage at −20 °C
2005 · David Ulmert, Charlotte Becker, et al. · Clinical Chemistry · 67
Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling
1998 · Timo Piironen, Bruno O. Villoutreix, et al. · Protein Science · 67
Specific Immunoassays for Detection of Intact and Cleaved Forms of the Urokinase Receptor
2004 · Timo Piironen, Birgitte Laursen, et al. · Clinical Chemistry · 64
High Plasma Levels of Intact and Cleaved Soluble Urokinase Receptor Reflect Immune Activation and Are Independent Predictors of Mortality in HIV-1-Infected Patients
2005 · Sisse Rye Ostrowski, Timo Piironen, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 61
Free, complexed and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate
1996 · Seth E. Lerner, Steven J. Jacobsen, et al. · Urology · 56
Significance and Metabolism of Complexed and Noncomplexed Prostate Specific Antigen Forms, and Human Glandular Kallikrein 2 in Clinically Localized Prostate Cancer Before and After Radical Prostatectomy
1999 · HANS LILJA, ALEXANDER HAESE, et al. · The Journal of Urology · 55
Soluble Urokinase Receptor Levels in Plasma During 5 Years of Highly Active Antiretroviral Therapy in HIV-1???Infected Patients
2004 · Sisse R. Ostrowski, Terese L. Katzenstein, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 52
Works count: 57
Citation count: 2,889
H-index: 30
I10-index: 38
Year
Topic
Type